Retatrutide 10mg - Pharmaqo Triple Agonist Formula
Experience the cutting edge of metabolic research with Retatrutide. As the most advanced peptide in the GLP-1 class, this triple-agonist formula offers unparalleled precision for your research requirements.
Specifications
| Active Substance | Retatnesside |
| Form | 1 vial x 10 mg + 1 amp x 1 ml bac.water |
| Manufacturer | Pharmaqo |
How it Works
Retatrutide (Eli Lilly code LY3437943) represents a breakthrough in peptide science. Unlike standard dual-agonists, this compound utilizes a triple-receptor mechanism. It targets GLP-1, GIP, and Glucagon pathways simultaneously. This unique action allows for powerful appetite control through GLP-1, improved insulin response via GIP, and increased energy expenditure through the glucagon arm, which helps mobilize liver fat. This multi-pathway approach makes it a highly effective tool for weight-loss research.
Whether you are looking for the most potent single-molecule agonist or seeking to compare results against semaglutide or tirzepatide, Retatrutide provides a high-performance solution for your studies.
Shipping & Delivery
All orders are processed via our US domestic warehouse (Warehouse 5) to ensure fast and discreet delivery. Please note that military addresses, including APO and FPO, are currently not supported.
FAQ
How effective is Retatrutide?
In clinical trials, Retatrutide demonstrated a mean body-weight loss of approximately 24%, outperforming both tirzepatide (~21%) and semaglutide (~15%).
Is this product authentic?
Yes. We are a preferred supplier for Pharmaqo. Every kit is genuine and includes a batch-linked third-party Certificate of Analysis (COA) for HPLC and Mass-Spec verification.
How should I prepare the solution?
The kit comes as 1 vial of 10mg with 1 ampoule of 1ml bacteriostatic water. The solution must be reconstituted with the included water for subcutaneous use.
Can I save money on my order?
Yes, we offer competitive bulk pricing and the best rates for customers paying with cryptocurrency.